Importantly, silencing CXCR3 in CRC cells effectively mitigated anti-Act1 macrophage-induced epithelial-mesenchymal transition (Fig. 4B (a-b)) and migration of CRC cells (Fig. 4C (a-b)). The gene discussed is TRAF3IP2; the disease is colorectal carcinoma.